#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Diabetes and obesity - Issue 43/2022

Editorial

6

Original paper

9

Relationship of glycemic variability and diabetes risk factors in pregnant women

Martina Gáborová, Viera Doničová

Reviews

16

From the adult type through NIDDM and second type of diabetes – what is coming thereafter?

Oliver Rácz, Eva Sedláková

20

Cardiovascular effect of GLP-1 receptor agonists: meta-analyses suggest a class effect

Peter Novodvorský

24

Use of SGLT2 inhibitors in type 2 diabetics at different stages of the cardiovascular continuum

Zbynek Schroner

30

Cardiorenal benefits of GLP-1 receptor agonists in the treatment of type 2 diabetes mellitus

Rid Dravecká

Case studies

34

Treatment with biosimilar insulin in routine clinical practice in Slovakia: case reports

Rid Bugáňová, Jana Ročiaková, Jozef Lacka, Zbynek Schroner

Clinical studies

39

Co-formulation of insulin degludec and insulin aspartate in realworld clinical practice: the ARISE study

Zbynek Schroner

44

Adipocytokines as possible etiopathogenetic mechanisms leading to a higher incidence of autoimmune thyroiditis in patients with type 2 diabetes mellitus – enlarged study

Štefan Sotak, Zbynek Schroner, Ivica Lazúrová, Ivana Jochmanová, Marek Felš Ci, Darina Petrášová, Izabela Bertková, Miriam Mitníková

News

52

Effect of GLP-1 receptor agonists on postprandial lipaemia: commentary on a review article

Peter Novodvorský

Personal news

54

Spomienka na MUDr. Danielu Kuzmovú

News

55

Virtuálny 26. World Diabetes Congress 2021

Andrea Bukovská

56

7. slovenský deň obezity: v liečbe obezity každý zaváži!

Ubomíra Fábryová

Diabetes and obesity

Issue 43

2022 Issue 43

Most read in this issue

#ADS_BOTTOM_SCRIPTS#